Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Revenue
5
6
15
15
Revenue Growth (YoY)
--
-60%
0%
--
Cost of Revenue
1
2
5
4
Gross Profit
3
4
10
11
Selling, General & Admin
1
1
0
0
Research & Development
--
--
--
--
Operating Expenses
3
3
3
2
Other Non Operating Income (Expenses)
--
--
--
--
Pretax Income
0
1
15
8
Income Tax Expense
--
0
0
0
Net Income
0
1
15
8
Net Income Growth
--
-93%
88%
--
Shares Outstanding (Diluted)
9.83
2.38
2.38
2.38
Shares Change (YoY)
--
0%
0%
--
EPS (Diluted)
0.03
0.44
6.46
3.62
EPS Growth
--
-93%
78%
--
Free Cash Flow
-31
6
-7
4
Free Cash Flow Per Share
--
--
--
--
Gross Margin
60%
66.66%
66.66%
73.33%
Operating Margin
0%
16.66%
46.66%
53.33%
Profit Margin
0%
16.66%
100%
53.33%
Free Cash Flow Margin
-620%
100%
-46.66%
26.66%
EBITDA
1
2
8
9
EBITDA Margin
20%
33.33%
53.33%
60%
D&A For EBITDA
1
1
1
1
EBIT
0
1
7
8
EBIT Margin
0%
16.66%
46.66%
53.33%
Effective Tax Rate
--
0%
0%
0%
Follow-Up Questions
What are Canopus Biopharma Inc's key financial statements?
According to the latest financial statement (Form-10K), Robin Energy Ltd has a total asset of $21, Net profit of $1
What are the key financial ratios for CBIA?
Robin Energy Ltd's Current ratio is 0, has a Net margin is 16.66, sales per share of $2.51.
How is Canopus Biopharma Inc's revenue broken down by segment or geography?
Robin Energy Ltd largest revenue segment is Japan Housing Equipment, at a revenue of 473,092,000,000 in the most earnings release.For geography, Japan is the primary market for Robin Energy Ltd, at a revenue of 473,092,000,000.
Is Canopus Biopharma Inc profitable?
yes, according to the latest financial statements, Robin Energy Ltd has a net profit of $1
Does Canopus Biopharma Inc have any liabilities?
no, Robin Energy Ltd has liability of 0
How many outstanding shares for Canopus Biopharma Inc?
Robin Energy Ltd has a total outstanding shares of 2.38